Summary
Objectives. S100B is an established marker of brain damage. Used in the context as a biochemical marker, S100B denotes a measurement of all S100 proteins, including at least one S100B monomer, i.e. the sum of the two dimers S100A1B and S100BB. Almost all published studies are based on this “sum concentration”. However, the brain specificity of S100B has been questioned and increased serum levels have also been reported after trauma without head injury. Since the S100B monomer dominates in the brain, we hypothesised that the S100BB dimer should be better related to outcome after severe traumatic brain injury than S100A1B or the “sum concentration”.
Methods. Daily serum samples were collected from 59 patients with severe traumatic brain injury. Three different ELISA methods were used for measurements of S100B, S100A1B and S100BB respectively. Outcome was assessed after one year and categorised according to the Glasgow Outcome Scale.
Results. Serum levels of S100B, S100A1B and S100BB followed the same temporal course, with early maximum and rapidly decreasing values over the first days after the trauma. Maximum serum concentrations of each of the parameters were increased in the patient group with an unfavourable outcome compared with those with a favourable outcome (p = 0.01, 0.006 and 0.004, respectively).
Conclusion. Both S100A1B and S100BB were related to outcome after severe traumatic brain injury. Even though this study is small, it seems unlikely that separate analyses of the dimers are of any advantage compared with measuring S100B alone.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
RE Anderson LO Hansson O Nilsson R Dijlai-Merzoug G Settergren (2001) ArticleTitleHigh Serum S100B levels for trauma patients without head injuries Neurosurgery 48 1255–1260 Occurrence Handle11383727 Occurrence Handle10.1097/00006123-200106000-00012 Occurrence Handle1:STN:280:DC%2BD3MzhtV2qsA%3D%3D
RE Anderson LO Hansson O Nilsson J Liska G Settergren J Vaage (2001) ArticleTitleIncrease in serum S100A1B and S100BB during cardiac surgery arises from extracerebral sources Ann Thorac Surg 71 1512–1517 Occurrence Handle11383792 Occurrence Handle10.1016/S0003-4975(01)02399-2 Occurrence Handle1:STN:280:DC%2BD3MzhtVeltA%3D%3D
RE Anderson A Winnerkvist LO Hansson O Nilsson L Rosengren G Settergren J Vaage (2003) ArticleTitleBiochemical markers of cerebrospinal ischemia after repair of aneurysms of the descending and thoracoabdominal aorta J Cardiothorac Vasc Anesth 17 598–603 Occurrence Handle14579213 Occurrence Handle10.1016/S1053-0770(03)00203-9
T Isobe N Ishioka T Masuda Y Takahashi S Ganno T Okyuama (1983) ArticleTitleA rapid separation of the S100 subunits by high performance liquid chromatography: the subunit compositions of S100 proteins Biochem Int 6 419–426 Occurrence Handle6679332 Occurrence Handle1:CAS:528:DyaL3sXhvFCgu78%3D
R Jensen DR Marshak C Anderson TJ Lukas DM Watterson (1985) ArticleTitleCharacterization of human brain S100 protein fraction: amino acid sequence of s100beta J Neurochem 45 700–705 Occurrence Handle4031854 Occurrence Handle10.1111/j.1471-4159.1985.tb04048.x Occurrence Handle1:CAS:528:DyaL2MXlsFKjsrk%3D
AA Kanner N Marchi V Fazio MR Mayberg MT Koltz V Siomin GH Stevens T Masaryk B Aumayr MA Vogelbaum GH Barnett D Janigro (2003) ArticleTitleSerum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions Cancer 97 2806–2813 Occurrence Handle12767094 Occurrence Handle10.1002/cncr.11409 Occurrence Handle1:CAS:528:DC%2BD3sXkslWrsL8%3D
M Kapural LJ Krizanac-Bengez G Barnett J Perl T Masaryk D Apollo P Rasmussen MR Mayberg D Janigro (2002) ArticleTitleSerum S-100beta as a possible marker of blood-brain barrier disruption Brain Res 940 102–104 Occurrence Handle12020881 Occurrence Handle10.1016/S0006-8993(02)02586-6 Occurrence Handle1:CAS:528:DC%2BD38XjvVShtL0%3D
LF Marshall SB Marshall MR Klauber M van Berkum Clark HM Eisenberg JA Jane TG Luerssen A Marmarou MA Foulkes (1991) ArticleTitleA new classification of head injury based on computerized tomography J Neurosurg 75 S14–S20
C Nygren de Boussard P Fredman A Lundin K Andersson G Edman J Borg (2004) ArticleTitleS100 in mild traumatic brain injury Brain Inj 18 671–683 Occurrence Handle15204328 Occurrence Handle10.1080/02699050310001646215
K Nylén M Öst LZ Csajbok I Nilsson K Blennow B Nellgård L Rosengren (2006) ArticleTitleIncreased serum-GFAP in patients with severe traumatic brain injury is related to outcome J Neurolog Sci 240 85–91 Occurrence Handle10.1016/j.jns.2005.09.007 Occurrence Handle1:CAS:528:DC%2BD2MXhtlCrt7rF
LE Pelinka L Szalay M Jafarmadar R Schmidhammer H Redl S Bahrami (2003) ArticleTitleCirculating S100B is increased after bilateral femur fracture without brain injury in the rat Br J Anaesth 91 595–597 Occurrence Handle14504167 Occurrence Handle10.1093/bja/aeg225 Occurrence Handle1:STN:280:DC%2BD3svot1Wntg%3D%3D
A Raabe C Grolms O Sorge M Zimmermann V Seifert (1999) ArticleTitleSerum S-100B protein in severe head injury Neurosurgery 45 477–483 Occurrence Handle10493369 Occurrence Handle10.1097/00006123-199909000-00012 Occurrence Handle1:STN:280:DyaK1MvitFWisA%3D%3D
A Raabe O Kopetsch A Woszczyk J Lang R Gerlach M Zimmermann V Seifert (2003) ArticleTitleSerum S-100B protein as a molecular marker in severe traumatic brain injury Restor Neurol Neurosci 21 159–169 Occurrence Handle14530578 Occurrence Handle1:CAS:528:DC%2BD3sXns1Kgsbw%3D
RD Rothoerl C Woertgen A Brawanski (2000) ArticleTitleS-100 serum levels and outcome after severe head injury Acta Neurochir Suppl 76 97–100 Occurrence Handle11450101 Occurrence Handle1:STN:280:DC%2BD3MzpvFWitA%3D%3D
BW Schafer CW Heizmann (1996) ArticleTitleThe S100 family of EF-hand calcium-binding proteins: functions and pathology Trends Biochem Sci 21 134–140 Occurrence Handle8701470 Occurrence Handle1:STN:280:DyaK283ntlWqsA%3D%3D
J Undén J Bellner M Eneroth C Alling T Ingebrigtsen B Romner (2005) ArticleTitleRaised serum S100B levels after acute bone fractures without cerebral injury J Trauma 58 59–61 Occurrence Handle15674151
J Undén J Bellner P Reinstrup B Romner (2004) ArticleTitleSerial S100B levels before, during and after cerebral herniation Br J Neurosurg 18 277–280 Occurrence Handle15327232 Occurrence Handle10.1080/02688690410001732742
JT Wilson LE Pettigrew GM Teasdale (1998) ArticleTitleStructured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use J Neurotrauma 15 573–585 Occurrence Handle9726257 Occurrence Handle1:STN:280:DyaK1czpt1ymug%3D%3D Occurrence Handle10.1089/neu.1998.15.573
C Woertgen RD Rothoerl C Metz A Brawanski (1999) ArticleTitleComparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury J Trauma 47 1126–1130 Occurrence Handle10608545 Occurrence Handle1:STN:280:DC%2BD3c%2FnsVamtQ%3D%3D
M Öst K Nylén L Csajbok AO Ohrfelt M Tullberg C Wikkelsö P Nellgård L Rosengren K Blennow B Nellgård (2006) ArticleTitleInitial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury Neurology 67 1600–1604 Occurrence Handle17101890 Occurrence Handle10.1212/01.wnl.0000242732.06714.0f Occurrence Handle1:CAS:528:DC%2BD28XhtFChsLjF
Author information
Authors and Affiliations
Corresponding author
Additional information
Correspondence: Dr. Karin Nylén, Department of Neurology, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden.
Rights and permissions
About this article
Cite this article
Nylén, K., Öst, M., Csajbok, L. et al. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury. Acta Neurochir (Wien) 150, 221–227 (2008). https://doi.org/10.1007/s00701-007-1489-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-007-1489-2